Navigation Links
Advanced post-mastectomy breast reconstruction improves women's psychosocial and sexual well-being
Date:10/23/2011

After a mastectomy, women who undergo breast reconstruction with tissue from their own abdomen experience significant gains in psychological, social, and sexual wellbeing as soon as three weeks after surgery. That is one of the conclusions of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The study's results provide new information to breast cancer survivors who are contemplating these types of breast reconstruction procedures.

The goal of breast reconstruction after a mastectomy is to restore the appearance of the breast and to improve women's psychological health after cancer treatment. But how successful is it? Recent studies on the health and wellbeing of women who undergo breast reconstruction have generated mixed findings.

To provide a clearer picture of women's mental and physical health following two advanced forms of breast reconstruction, Toni Zhong, MD, MHS, of the University Health Network Breast Restoration Program at the University of Toronto in collaboration with her colleagues at Memorial Sloan Kettering Cancer Center in New York City surveyed 51 women undergoing free MS-TRAM or DIEP flap reconstruction between June 2009 and November 2010. During these procedures, which are gaining popularity in North America and Europe, surgeons take tissue from the patient's abdomen and use it to reconstruct the breast. The women in the study completed questionnaires prior to surgery and following surgery at three weeks and three months.

Women who underwent the breast reconstruction procedures reported significant improvements in psychological, social, and sexual wellbeing just three weeks after surgery. Unfortunately, however, they continued to experienced decreased physical wellbeing at the abdominal location where tissue was removed at three months following surgery.

The results may be helpful to breast cancer survivors who are considering breast reconstruc
'/>"/>

Contact: Amy Molnar
healthnews@wiley.com
Wiley-Blackwell
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. More surgery in early-stage laryngeal cancer treatment; more chemoradiation for advanced-stage
2. University of Colorado Cancer Center test helps reduce risk of death in advanced lung cancer
3. $9.55 million NCI grant targets the resistance of advanced prostate cancer
4. U.S. Scientists Map Genome of Advanced Prostate Cancer
5. New hope for advanced post-menopausal breast cancer patients resistant to hormonal therapy
6. MRI predicts survival in locally advanced rectal cancer
7. Major advanced cancer study to be led by Uppsala University
8. New treatment option for advanced prostate cancer
9. Distance caregivers for advanced cancer patients have special needs, CWRU study finds
10. UT Southwestern scientists discover new pathway to potential therapies for advanced prostate cancer
11. YERVOY (ipilimumab) approved for the treatment of previously treated advanced melanoma in the EU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... (HealthDay News) -- Hundreds of thousands of Americans ... potentially life-threatening liver complications over the next few ... evaluated medical insurance claims data and found that ... liver disease in 2008, and estimated that another ... 2015. The risk of developing advanced liver ...
(Date:5/22/2012)... May 22 Intensive care units (ICUs) that have ... the day can improve patient outcomes by having the ... to a study led by researchers at the University ... researchers were unable to find any incremental benefit of ... the specialists during the day. The findings were published ...
(Date:5/22/2012)... The national gastroenterology societies have issued a new ... The Multisociety Sedation Curriculum for Gastrointestinal Endoscopy ... complete and programmatic approach to the training of ... Gastroenterology , American Journal of Gastroenterology ... and in Gastroenterology Nursing . , ...
(Date:5/22/2012)... determined the genome sequences of a dozen strains ... be resistant to vancomycin, an antibiotic of last ... in each strain, and identified shared features among ... vancomycin resistance and evade human immune defenses. ... a leading cause of hospital-acquired infections in the ...
(Date:5/22/2012)... May 22 (HealthDay News) -- Fear of spiders, a ... single therapy session, according to a small new study. ... to touch or hold a tarantula after a two- ... therapy continued for at least six months, the Northwestern ... brain,s response to fear after short-term therapy seen in ...
Breaking Medicine News(10 mins):Health News:Hepatitis C Causing Liver Damage in Greater Numbers: Study 2Health News:Intensivists at night improve patient outcomes in some ICUs, says Pitt/UPMC team 2Health News:Gastroenterology Societies issue sedation curriculum for gastrointestinal endoscopy 2Health News:Genomes show how Staph bacteria gain resistance to last-line drug 2Health News:Spider-Phobes May Get Quick Relief 2
... 26 AARP in Maryland,853,000 members strong, urges ... strengthen the State Children,s Health Insurance Program (SCHIP) ... the state to call the President and tell ... than 100,000 children in Maryland rely on SCHIP ...
... announced the release of $131 million in energy assistance ... energy costs. The,Low Income Home Energy Assistance Program (LIHEAP) ... the fall and winter months,ahead. "No one should ... put states in a better position to help those ...
... 26 Science,Applications International Corporation (NYSE: SAI ... $38 million task order from the U.S. military ... (TMIP-J). The single-award, cost-plus-fixed-fee task order has ... options. The task order was,awarded under the Defense ...
... its ongoing dedication to,serving military members and their families, ... of Fleet Week San Diego, a,month-long celebration of Southern ... 11th year on Sept. 17 and continues until,Oct. 27 ... economic and,cultural importance of military personnel in San Diego, ...
... For many women, digestive issues,have gone from doctor,s ... nearly half of women surveyed say they care,about this ... video from General Mills (NYSE: GIS ) at:, ... is by consuming what are called probiotics.,Probiotics help people ...
... controlled with newer treatments , , WEDNESDAY, Sept. 26 (HealthDay ... small number of longtime HIV patients with mild cases ... plagued people with AIDS. , It,s not clear why ... may pose a significant health threat to AIDS patients. ...
Other Medicine News:Health News:HHS Provides Over $131 Million In Energy Assistance 2Health News:SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint 2Health News:TriWest On Deck to Support Fleet Week San Diego 2Health News:Doctors See Return of Kaposi's Sarcoma in Handful of AIDS Patients 2
(Date:5/22/2012)... NEW YORK, May 22, 2012  Fox Insurance Company, ... York, NY, announces the confirmation of a judgment in ... pharmacy benefit manager, in excess of $3.3 million, following ... negligence and breach of contract.  On May 21, 2012, ... Georgia, Atlanta Division, issued its decision confirming the arbitration ...
(Date:5/22/2012)... MOUNTAIN VIEW, Calif., May 22, 2012  Based ... market, Frost & Sullivan recognizes Labcyte Inc. with ... for its Echo liquid handler. While various liquid ... incorporates the wide range of advantages provided by ... to revolutionize liquid handling, Labcyte developed a platform ...
(Date:5/22/2012)... Conn., May 22, 2012   Valeritas , ... a new, simple disposable device for the delivery ... 2 diabetes, has selected dLife to ... number-one resource and community network for people living ... V-Go Life, a comprehensive diabetes lifestyle management and ...
Breaking Medicine Technology:Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager 2Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 2Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 3Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 4Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market 5Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 2Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 3Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device 4Scripps scientists see the light in bizarre bioluminescent snail 16922 1Scripps scientists see the light in bizarre bioluminescent snail 16922 2Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 1Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 2Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 3Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A 623 Antheras Investigational Novel Peptibody Agent 13285 4Fighting flu in newborns begins in pregnancy 77841 1Fighting flu in newborns begins in pregnancy 77841 2
... JMR-132 could provide a new therapeutic approach for ... CITY, April 17, 2007 /PRNewswire-FirstCall/ - AEterna,Zentaris Inc. ... endocrine therapy and oncology, today presented an,abstract outlining ... antagonist JMR-132 in breast cancer, at the American,Association ...
... previously announced, primary endpoint not met; plausibly,confounded ... ERBITUX,-, NEW YORK, April 16, 2007 /PRNewswire-FirstCall/ ... today,announced detailed results from the EPIC study ... - comparing ERBITUX(R),(Cetuximab) plus irinotecan to irinotecan ...
Other Medicine Technology:AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist,JMR-132 at the AACR Annual Meeting in Los Angeles 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
... This increased magnification all glass (1.5x) ... details with more ease., The 4 mirror ... for static and dynamic gonioscopy and features ... high magnification to appreciate details previously unattainable ...
Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
... P2000 Pachymeter [i.e., PalmScan P2000] device ... biometer, which incorporates A-mode pulsed-echo ultrasound,technology, ... accurately measure the corneal thickness (CT) ... PalmScan P2000 includes two software user,interfaces; ...
... A-Scan [i.e., PalmScan A2000] device is intended ... A-mode pulsed-echo ultrasound,technology, and thus may be ... (AL), anterior,chamber depth (ACD), and lens thickness ... is also intended for calculating the optical ...
Medicine Products: